Immunic AG | WebDisclosure

Basculer en Français

11293	Companies
250967	Keywords
179878	Articles
136836	Press releases

Home
Companies
Immunic AG

BRIEF

published on 11/02/2026 at 12:35, 5 days 3 hours ago

Immunisé pour participer aux principales conférences d'investisseurs de novembre

Biotechnologie Sclérose En Plaques Conférences D'investisseurs Immunitaire Maladies Neurologiques
BRIEF

published on 11/02/2026 at 12:35, 5 days 3 hours ago

Immunic to Participate in Key November Investor Conferences

Biotechnology Investor Conferences Multiple Sclerosis Immunic Neurologic Diseases
PRESS RELEASE

published on 11/02/2026 at 12:30, 5 days 3 hours ago

Immunic to Participate in Investor Conferences in November
BRIEF

published on 10/29/2026 at 11:35, 9 days 4 hours ago

Journée virtuelle de recherche et développement sur les schémas immunitaires pour la sclérose en plaques progressive

Effets Neuroprotecteurs Essai De Phase 3 Sclérose En Plaques Progressive Calcium De Vidofludimus Événement Virtuel De R&D
BRIEF

published on 10/29/2026 at 11:35, 9 days 4 hours ago

Immunic Schedules Virtual R&D Day for Progressive Multiple Sclerosis

Phase 3 Trial Vidofludimus Calcium Neuroprotective Effects Progressive MS Virtual R&D Event
PRESS RELEASE

published on 10/29/2026 at 11:30, 9 days 4 hours ago

Immunic to Host Virtual Progressive Multiple Sclerosis R&D Day on November 5, 2026
BRIEF

published on 10/21/2026 at 13:05, 17 days 2 hours ago

Immunic Reveals Promising Data for Vidofludimus Calcium at MSToronto2026

Clinical Data Multiple Sclerosis Immunic Vidofludimus Calcium Neuroprotection
BRIEF

published on 10/21/2026 at 13:05, 17 days 2 hours ago

Immunic présente des données prometteuses sur le Vidofludimus Calcium au congrès MSToronto2026

Sclérose En Plaques Vidofludimus Calcium Immunitaire Neuroprotection Données Cliniques
PRESS RELEASE

published on 10/21/2026 at 13:00, 17 days 2 hours ago

Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 – the 10th Joint ACTRIMS-ECTRIMS Meeting
Immunic presents new clinical, biomarker, and preclinical data for Vidofludimus Calcium in four poster presentations at MSToronto2026. Significant findings supporting treatment effects and disease progression in multiple sclerosis patients

Clinical Data Multiple Sclerosis Immunic Vidofludimus Calcium MSToronto2026
BRIEF

published on 10/19/2026 at 12:35, 19 days 3 hours ago

Immunic Names Jaa Roberson as Chief People Officer

Chief People Officer Multiple Sclerosis Immunic Vidofludimus Calcium Jaa Roberson

Accesswire

Published on 11/06/2026 at 22:15, 17 hours 28 minutes ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 2 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 3 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 3 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 1 day 5 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/07/2026 at 13:35, 2 hours 8 minutes ago

Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 19 hours 28 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 19 hours 28 minutes ago

L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 20 hours 28 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 20 hours 43 minutes ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet

Les Echos

Published on 11/06/2026 at 19:06, 20 hours 36 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 20 hours 39 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 20 hours 41 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 20 hours 43 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 18:00, 21 hours 43 minutes ago

ICADE - CP - Notation crédit S&P

View all LES ECHOS COMFI WIRE